The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene ...
Zacks.com on MSN19h
KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease DrugKrystal Biotech KRYS announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
Zacks Small Cap Research on MSN21h
LGND: First Steps into Cell & Gene TherapyLGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported 2024 financial and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback